Video Info Alkermes and Takeda are Leading a Revolution in Narcolepsy Treatment Alkermes' Alixorexton and Takeda's Oveporexton are leading a revolution in narcolepsy treatment, with promising results in Phase 2 and 3 trials. These OX2R receptor agonists offer hope for patients with narcolepsy type 1, improving wakefulness and reducing cataplexy. Comment comments debug Comments Write a comment Write a comment Share Your Thoughts Be the first to write a comment. GLP-1 Agonists Redefine Cardiac Care Alkermes and Takeda in Narcolepsy Treatment Novartis Invests Against Heart Disease A New Pathway for IMGs to Practice in the U.S. Respond to Trump's claims about acetaminophen 'Nightmare bacteria' cases Caution after measles virus detected in Oswego Experimental gene therapy slows Huntington's disease GLP-1 Agonists Redefine Cardiac Care Alkermes and Takeda in Narcolepsy Treatment Novartis Invests Against Heart Disease A New Pathway for IMGs to Practice in the U.S. Respond to Trump's claims about acetaminophen 'Nightmare bacteria' cases Caution after measles virus detected in Oswego Experimental gene therapy slows Huntington's disease GLP-1 Agonists Redefine Cardiac Care Alkermes and Takeda in Narcolepsy Treatment Novartis Invests Against Heart Disease A New Pathway for IMGs to Practice in the U.S. Respond to Trump's claims about acetaminophen 'Nightmare bacteria' cases Caution after measles virus detected in Oswego Experimental gene therapy slows Huntington's disease GLP-1 Agonists Redefine Cardiac Care Alkermes and Takeda in Narcolepsy Treatment Novartis Invests Against Heart Disease A New Pathway for IMGs to Practice in the U.S. Respond to Trump's claims about acetaminophen 'Nightmare bacteria' cases Caution after measles virus detected in Oswego Experimental gene therapy slows Huntington's disease Go Return Go

Video Info It’s an early warning system” Health commissioner urges caution after measles virus detected in Oswego The New York State Department of Health has issued an alert after traces of the measles virus were detected in wastewater from a treatment plant serving Oswego and nearby areas. Comment comments debug Comments Write a comment Write a comment Share Your Thoughts Be the first to write a comment. GLP-1 Agonists Redefine Cardiac Care Alkermes and Takeda in Narcolepsy Treatment Novartis Invests Against Heart Disease A New Pathway for IMGs to Practice in the U.S. Respond to Trump's claims about acetaminophen 'Nightmare bacteria' cases Caution after measles virus detected in Oswego Experimental gene therapy slows Huntington's disease GLP-1 Agonists Redefine Cardiac Care Alkermes and Takeda in Narcolepsy Treatment Novartis Invests Against Heart Disease A New Pathway for IMGs to Practice in the U.S. Respond to Trump's claims about acetaminophen 'Nightmare bacteria' cases Caution after measles virus detected in Oswego Experimental gene therapy slows Huntington's disease GLP-1 Agonists Redefine Cardiac Care Alkermes and Takeda in Narcolepsy Treatment Novartis Invests Against Heart Disease A New Pathway for IMGs to Practice in the U.S. Respond to Trump's claims about acetaminophen 'Nightmare bacteria' cases Caution after measles virus detected in Oswego Experimental gene therapy slows Huntington's disease GLP-1 Agonists Redefine Cardiac Care Alkermes and Takeda in Narcolepsy Treatment Novartis Invests Against Heart Disease A New Pathway for IMGs to Practice in the U.S. Respond to Trump's claims about acetaminophen 'Nightmare bacteria' cases Caution after measles virus detected in Oswego Experimental gene therapy slows Huntington's disease Go Return Go

Video Info 'Nightmare bacteria' cases are increasing in the US Government scientists say infection rates from drug-resistant “nightmare bacteria” have been increasing dramatically. Comment comments debug Comments Write a comment Write a comment Share Your Thoughts Be the first to write a comment. GLP-1 Agonists Redefine Cardiac Care Alkermes and Takeda in Narcolepsy Treatment Novartis Invests Against Heart Disease A New Pathway for IMGs to Practice in the U.S. Respond to Trump's claims about acetaminophen 'Nightmare bacteria' cases Caution after measles virus detected in Oswego Experimental gene therapy slows Huntington's disease GLP-1 Agonists Redefine Cardiac Care Alkermes and Takeda in Narcolepsy Treatment Novartis Invests Against Heart Disease A New Pathway for IMGs to Practice in the U.S. Respond to Trump's claims about acetaminophen 'Nightmare bacteria' cases Caution after measles virus detected in Oswego Experimental gene therapy slows Huntington's disease GLP-1 Agonists Redefine Cardiac Care Alkermes and Takeda in Narcolepsy Treatment Novartis Invests Against Heart Disease A New Pathway for IMGs to Practice in the U.S. Respond to Trump's claims about acetaminophen 'Nightmare bacteria' cases Caution after measles virus detected in Oswego Experimental gene therapy slows Huntington's disease GLP-1 Agonists Redefine Cardiac Care Alkermes and Takeda in Narcolepsy Treatment Novartis Invests Against Heart Disease A New Pathway for IMGs to Practice in the U.S. Respond to Trump's claims about acetaminophen 'Nightmare bacteria' cases Caution after measles virus detected in Oswego Experimental gene therapy slows Huntington's disease Go Return Go

Video Info Novartis Invests Heavily Against Inflammation in Heart Disease Novartis acquires Tourmaline Bio for $1.4 billion, focusing on pacibekitug, a drug that combats inflammation in heart disease like ASCVD, promising significant advancements in cardiovascular treatment. Comment comments debug Comments Write a comment Write a comment Share Your Thoughts Be the first to write a comment. GLP-1 Agonists Redefine Cardiac Care Alkermes and Takeda in Narcolepsy Treatment Novartis Invests Against Heart Disease A New Pathway for IMGs to Practice in the U.S. Respond to Trump's claims about acetaminophen 'Nightmare bacteria' cases Caution after measles virus detected in Oswego Experimental gene therapy slows Huntington's disease GLP-1 Agonists Redefine Cardiac Care Alkermes and Takeda in Narcolepsy Treatment Novartis Invests Against Heart Disease A New Pathway for IMGs to Practice in the U.S. Respond to Trump's claims about acetaminophen 'Nightmare bacteria' cases Caution after measles virus detected in Oswego Experimental gene therapy slows Huntington's disease GLP-1 Agonists Redefine Cardiac Care Alkermes and Takeda in Narcolepsy Treatment Novartis Invests Against Heart Disease A New Pathway for IMGs to Practice in the U.S. Respond to Trump's claims about acetaminophen 'Nightmare bacteria' cases Caution after measles virus detected in Oswego Experimental gene therapy slows Huntington's disease GLP-1 Agonists Redefine Cardiac Care Alkermes and Takeda in Narcolepsy Treatment Novartis Invests Against Heart Disease A New Pathway for IMGs to Practice in the U.S. Respond to Trump's claims about acetaminophen 'Nightmare bacteria' cases Caution after measles virus detected in Oswego Experimental gene therapy slows Huntington's disease Go Return Go

Video Info North Carolina's Game-Changing Senate Bill 336: A New Pathway for IMGs to Practice in the U.S. Forget everything you thought you knew about the path to licensure for International Medical Graduates (IMGs) in the United States. North Carolina has rolled out a groundbreaking new state bill, Senate Bill 336, that could revolutionize the process. This isn't clickbait. The state is creating a new avenue that could allow eligible IMGs to obtain a license with no USMLE exams and no U.S. residency required. Comment comments debug Comments Write a comment Write a comment Share Your Thoughts Be the first to write a comment. GLP-1 Agonists Redefine Cardiac Care Alkermes and Takeda in Narcolepsy Treatment Novartis Invests Against Heart Disease A New Pathway for IMGs to Practice in the U.S. Respond to Trump's claims about acetaminophen 'Nightmare bacteria' cases Caution after measles virus detected in Oswego Experimental gene therapy slows Huntington's disease GLP-1 Agonists Redefine Cardiac Care Alkermes and Takeda in Narcolepsy Treatment Novartis Invests Against Heart Disease A New Pathway for IMGs to Practice in the U.S. Respond to Trump's claims about acetaminophen 'Nightmare bacteria' cases Caution after measles virus detected in Oswego Experimental gene therapy slows Huntington's disease GLP-1 Agonists Redefine Cardiac Care Alkermes and Takeda in Narcolepsy Treatment Novartis Invests Against Heart Disease A New Pathway for IMGs to Practice in the U.S. Respond to Trump's claims about acetaminophen 'Nightmare bacteria' cases Caution after measles virus detected in Oswego Experimental gene therapy slows Huntington's disease GLP-1 Agonists Redefine Cardiac Care Alkermes and Takeda in Narcolepsy Treatment Novartis Invests Against Heart Disease A New Pathway for IMGs to Practice in the U.S. Respond to Trump's claims about acetaminophen 'Nightmare bacteria' cases Caution after measles virus detected in Oswego Experimental gene therapy slows Huntington's disease Go Return Go

Video Info Health experts respond to Trump's claims linking autism to acetaminophen President Trump tied the use of acetaminophen during pregnancy to autism and made several other claims about vaccines. William Brangham discussed those claims and the concerns about what the president said with Alycia Halladay of the Autism Science Foundation and Jennifer Nuzzo of Brown University’s School of Public Health. Watch PBS News for daily, breaking and live news, plus special coverage. We are home to PBS News Hour, ranked the most credible and objective TV news show. Comment comments debug Comments Write a comment Write a comment Share Your Thoughts Be the first to write a comment. GLP-1 Agonists Redefine Cardiac Care Alkermes and Takeda in Narcolepsy Treatment Novartis Invests Against Heart Disease A New Pathway for IMGs to Practice in the U.S. Respond to Trump's claims about acetaminophen 'Nightmare bacteria' cases Caution after measles virus detected in Oswego Experimental gene therapy slows Huntington's disease GLP-1 Agonists Redefine Cardiac Care Alkermes and Takeda in Narcolepsy Treatment Novartis Invests Against Heart Disease A New Pathway for IMGs to Practice in the U.S. Respond to Trump's claims about acetaminophen 'Nightmare bacteria' cases Caution after measles virus detected in Oswego Experimental gene therapy slows Huntington's disease GLP-1 Agonists Redefine Cardiac Care Alkermes and Takeda in Narcolepsy Treatment Novartis Invests Against Heart Disease A New Pathway for IMGs to Practice in the U.S. Respond to Trump's claims about acetaminophen 'Nightmare bacteria' cases Caution after measles virus detected in Oswego Experimental gene therapy slows Huntington's disease GLP-1 Agonists Redefine Cardiac Care Alkermes and Takeda in Narcolepsy Treatment Novartis Invests Against Heart Disease A New Pathway for IMGs to Practice in the U.S. Respond to Trump's claims about acetaminophen 'Nightmare bacteria' cases Caution after measles virus detected in Oswego Experimental gene therapy slows Huntington's disease Go Return Go